These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067 [Abstract] [Full Text] [Related]
3. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Granado M, Martín AI, Villanúa MA, López-Calderón A. Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570 [Abstract] [Full Text] [Related]
4. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats. Granado M, Priego T, Martín AI, Vara E, López-Calderón A, Angeles Villanúa M. Eur J Pharmacol; 2006 Apr 24; 536(1-2):204-10. PubMed ID: 16545800 [Abstract] [Full Text] [Related]
5. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3. López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A. Am J Physiol Regul Integr Comp Physiol; 2010 Aug 24; 299(2):R541-51. PubMed ID: 20519361 [Abstract] [Full Text] [Related]
6. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats. Gomez-Sanmiguel AB, Nieto-Bona MP, Fernandez-Galaz C, Priego T, Martin AI, Lopez-Calderon A. J Physiol Pharmacol; 2017 Apr 24; 68(2):191-199. PubMed ID: 28614768 [Abstract] [Full Text] [Related]
7. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L, Han J, Meng Q, Xi Q, Zhuang Q, Jiang Y, Han Y, Zhang B, Fang J, Wu G. Oncol Rep; 2015 May 24; 33(5):2261-8. PubMed ID: 25760630 [Abstract] [Full Text] [Related]
8. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors. Castillero E, Martín AI, López-Menduiña M, Villanúa MA, López-Calderón A. Am J Physiol Regul Integr Comp Physiol; 2009 Nov 24; 297(5):R1322-31. PubMed ID: 19741054 [Abstract] [Full Text] [Related]
9. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats. López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A. Growth Horm IGF Res; 2012 Feb 24; 22(1):22-9. PubMed ID: 22244673 [Abstract] [Full Text] [Related]
10. Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training. Adams V, Linke A, Gielen S, Erbs S, Hambrecht R, Schuler G. Eur J Cardiovasc Prev Rehabil; 2008 Jun 24; 15(3):293-9. PubMed ID: 18525383 [Abstract] [Full Text] [Related]
12. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. Dehoux MJ, van Beneden RP, Fernández-Celemín L, Lause PL, Thissen JP. FEBS Lett; 2003 Jun 05; 544(1-3):214-7. PubMed ID: 12782319 [Abstract] [Full Text] [Related]
13. Lipid accumulation and mitochondrial abnormalities are associated with fiber atrophy in the skeletal muscle of rats with collagen-induced arthritis. Vial G, Coudy-Gandilhon C, Pinel A, Wauquier F, Chevenet C, Béchet D, Wittrant Y, Coxam V, Soubrier M, Tournadre A, Capel F. Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb 05; 1865(2):158574. PubMed ID: 31747539 [Abstract] [Full Text] [Related]
17. Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I. Lang CH, Huber D, Frost RA. Am J Physiol Regul Integr Comp Physiol; 2007 Jan 05; 292(1):R328-36. PubMed ID: 16946078 [Abstract] [Full Text] [Related]
18. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells. Krawiec BJ, Nystrom GJ, Frost RA, Jefferson LS, Lang CH. Am J Physiol Endocrinol Metab; 2007 Jun 05; 292(6):E1555-67. PubMed ID: 17264220 [Abstract] [Full Text] [Related]
19. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A. Am J Physiol Endocrinol Metab; 2011 May 05; 300(5):E790-9. PubMed ID: 21304067 [Abstract] [Full Text] [Related]